Albert Labs International Corp. (CSE:ABRT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Jul 15, 2024, 9:38 AM EDT
-85.71%
Market Cap372.07K
Revenue (ttm)n/a
Net Income (ttm)-2.31M
Shares Out74.41M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume22,965
Openn/a
Previous Close0.0050
Day's Range0.0050 - 0.0050
52-Week Range0.0050 - 0.0350
Beta2.63
RSI39.48
Earnings DateAug 28, 2025

About Albert Labs International

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Navchand Jagpal
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol ABRT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.